A model of type 2 diabetes in the guinea pig using sequential diet-induced glucose intolerance and streptozotocin treatment.

作者: Brendan K. Podell , David F. Ackart , Michael A. Richardson , James E. DiLisio , Bruce Pulford

DOI: 10.1242/DMM.025593

关键词:

摘要: Type 2 diabetes is a leading cause of morbidity and mortality among noncommunicable diseases, additional animal models that more closely replicate the pathogenesis human type are needed. The goal this study was to develop model in guinea pigs, which diet-induced glucose intolerance precedes β-cell cytotoxicity, two processes crucial development diabetes. Guinea pigs developed impaired tolerance after 8 weeks feeding on high-fat, high-carbohydrate diet, as determined by oral challenge. Diet-induced accompanied hyperplasia, compensatory hyperinsulinemia, dyslipidemia with hepatocellular steatosis. Streptozotocin (STZ) treatment alone ineffective at inducing diabetic hyperglycemia failed sustained or fasting returned euglycemia within 21 days treatment. However, when diet-fed were treated STZ, persisted beyond post-STZ subsequently STZ demonstrated an insulin-secretory capacity consistent insulin-independent This state confirmed response antihyperglycemic drugs, metformin glipizide, resolved extended survival compared uncontrolled In study, we have sequential loss, through diet extensive optimization pig, resembles will prove useful without comorbidities, where pig serves relevant species.

参考文章(69)
Christopher Bell, Randall J. Basaraba, Brendan K. Podell, David F. Ackart, Natalie M. Kirk, Sarah P. Eck, Non-Diabetic Hyperglycemia Exacerbates Disease Severity in Mycobacterium tuberculosis Infected Guinea Pigs PLoS ONE. ,vol. 7, pp. e46824- ,(2012) , 10.1371/JOURNAL.PONE.0046824
Ele Ferrannini, Amalia Gastaldelli, Yoshinori Miyazaki, Masafumi Matsuda, Andrea Mari, Ralph A. DeFronzo, β-Cell Function in Subjects Spanning the Range from Normal Glucose Tolerance to Overt Diabetes: A New Analysis The Journal of Clinical Endocrinology and Metabolism. ,vol. 90, pp. 493- 500 ,(2005) , 10.1210/JC.2004-1133
M.J Reed, K Meszaros, L.J Entes, M.D Claypool, J.G Pinkett, T.M Gadbois, G.M Reaven, A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat. Metabolism-clinical and Experimental. ,vol. 49, pp. 1390- 1394 ,(2000) , 10.1053/META.2000.17721
Anna Garofano, Paul Czernichow, Bernadette BrÉant, Impaired β-cell regeneration in perinatally malnourished rats: a study with STZ The FASEB Journal. ,vol. 14, pp. 2611- 2617 ,(2000) , 10.1096/FJ.00-0015COM
Mervyn Griffiths, The mechanism of the hypoglycemic action of alloxan. Immunology and Cell Biology. ,vol. 26, pp. 339- 346 ,(1948) , 10.1038/ICB.1948.35
Kristy L. West, Maria Fernandez, Guinea pigs as models to study the hypocholesterolemic effects of drugs. Cardiovascular Drug Reviews. ,vol. 22, pp. 55- 70 ,(2006) , 10.1111/J.1527-3466.2004.TB00131.X
Richard H. Bell, Robert J. Hye, Animal models of diabetes mellitus: physiology and pathology. Journal of Surgical Research. ,vol. 35, pp. 433- 460 ,(1983) , 10.1016/0022-4804(83)90034-3
M. Elsner, B. Guldbakke, M. Tiedge, R. Munday, S. Lenzen, Relative importance of transport and alkylation for pancreatic beta-cell toxicity of streptozotocin. Diabetologia. ,vol. 43, pp. 1528- 1533 ,(2000) , 10.1007/S001250051564
B. Kushner, M. Lazar, M. Furman, T. W. Lieberman, I. H. Leopold, Resistance of rabbits and guinea pigs to the diabetogenic effect of streptozotocin. Diabetes. ,vol. 18, pp. 542- 544 ,(1969) , 10.2337/DIAB.18.8.542